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S_ry The type rather than the amount of dietary fat may be more important in breast carciogenesis.
While animal studies support this view, little is known about the effects of essential fatty acids (EFAs) at the
cellular level. The MCF-7 breast cancer and the MCF-IOA non-cancerous human mammary epithelial cell
lines are compared in terms of growth response to EFAs and ability to incorporate and process the EFAs.
Eicosapentaenoic (EPA, n-3) and docosahexaenoic (DHA, n-3) acids, presented bound to albumin, inhibited
the growth of MCF-7 cells by as much as 50% in a dose-dependent manner (6-30 jm) in medium containing
0.5% serum. ai-Linokenic (LNA, n-3) and arachidonic (AA, n-6) acids inhibited growth less extensively, whik
linoleic acid (LA, n-6) had no effect. In contrast, MCF-1OA cells were not inhibited by any of the EFAs at
levels below 24 m. The differential effects of AA, EPA and DHA on MCF-7 and MCF-1OA cells support a
protective role of highly unsaturated essential fatty acids against breast cancer. The EFAs were primarily
incorporated into phosphoglycerides. MCF-7 cells showed chain elongations and possibly Am desaturation, but
no AA was formed from LA, nor EPA or DHA from LNA. In contrast, MCF-1OA cells desaturated and
elongated the exogenous EFAs via all the known pathways. These findings suggest defects in the desaturating
enzymes of MCF-7 ceils. LNA, DHA and AA presented to MCF-7 cells in phospholipid liposomes inhibited
growth as extensively as albumin-bound free acids, but were less extensively incorporated, suggesting different
mechanisms of inhibition for the two methods.
Differences in the rates of breast cancer incidence among
women in different countries and corresponding changes in
the incidence of breast cancer for women who migrate from
an area of lower incidence to one of higher incidence suggest
that environmental factors such as dietary fat may play a
role in this disease (Buell, 1978; Armstrong & Doll, 1975).
Epidemiological studies testing this hypothesis have produced
conflicting results (Wynder et al., 1986; Willet et al., 1992).
The apparent lack of correlation between total dietary fat
intake and the incidence of breast cancer led to the idea that
the type of fatty acid (FA) in the diet might play a more
important role in carcinogenesis than total dietary fat (Cave,
1991). The type of FA can have a direct effect because,
unlike proteins and carbohydrates, FAs are incorporated
directly into membranes. In particular, the essential FAs (n-3
and n-6, EFAs), which mammals cannot synthesise, are either
incorporated intact or converted to other FAs of the same
family. Experiments in rat models showed that diets rich in
linoleic acid (18:2 6,. LA) increased the incidence and metas-
tasis of chemically induced and transplanted mammary
tumours (Carroll & Hopkins, 1979; Hubbard & Erickson,
1987; Katz & Boylan, 1987). Conversely, diets rich in n-3
FAs, such as a-linolenic (18:3, LNA), eicosapentaenoic (20:5,
EPA) and docosahexaenoic (22:6, DHA) acids, reduced the
incidence, growth and metastasis of both induced and trans-
planted rat mammary tumours (Pritchard et al., 1989; Cave,
1991). These results could explain the increasing incidence of
breast cancer in the USA, where LA-rich vegetable oil con-
sumption has steadily increased, as well as the lower inci-
dence in countries where fish oils (rich in n-3 FAs) constitute
a higher proportion of the dietary lipid intake (Carroll &
Hopkins, 1979; Kaizer et al., 1989).
The effects of n-6 and n-3 FAs on mammary carcinogenesis
may be direct, involving the mammary cells at any step in the
carcinogenic process, or may be mediated by accessory cells
or organs. Possible mechanisms include increased peroxida-
tion of FAs with a high degree of unsaturation, modification
of membrane structure and function and modulation of sig-
nal transduction, eicosanoid hormone levels and gene expres-
sion. Since the membrane FA composition of cells in culture
can be modified without changing the cholesterol, phospho-
lipid or protein content (Spector & Burns, 1987), these
mechanisms can be investigated in vitro at the cellular level.
To date, there have been very few attempts to study the
effects of dietary FAs on breast cancer at the cellular level
(Wicha et al., 1979; Rose & Connolly, 1990).
The intracellular fate of exogenous EFAs is of central
importance to any study of the effect of dietary fat at the
cellular level. The EFAs can theoretically undergo stepwise
two-carbon chain elongations or shortenings, as well as
desaturations or saturations, leading to a variety of FAs of
the same family (Figure 1). Although processing of this type
is believed to occur primarily in the liver, the desaturating
and elongating ability of a variety of primary cell cultures
and cell lines has been demonstrated (reviewed by Rosenthal,
1987). While many transformed or malignant cells have
limited capacity to perform FA desaturations (Dunbar &
Bailey, 1975; Iturralde et al., 1990; Marra & de Alaniz, 1992;
Naval et al., 1993), very little is known about the ability of
cancerous and normal human mammary epithelial cells to
elongate and/or desaturate exogenous FAs in culture.
In this report we compare the MCF-7 human breast cancer
cell line (Soule et al., 1973) with the recently established
non-cancerous human mammary epithelial cell line MCF-
lOA (Soule et al., 1990) in terms of growth response to the
n-6 FAs LA and AA, and to the n-3 FAs LNA, EPA and
DHA. We also compare their ability to incorporate, elongate
and desaturate these FAs. Our findings indicate important
differences between the two cell lines and set the stage for an
evaluation of dietary fatty acid effects on cultured human
mammary cells from all stages of the carcinogenic pro-
cess.
Materis and methods
Materials
Milhi-Q water (Millipore) was used throughout. Stabilised
bovine fibronectin was purchased from Biomedical Tech-
nologies (Stoughton, MA, USA); Miles Pentex bovine serum
albumin (BSA, fraction V, fatty acid-free, very low
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Fge 1 Metabolism of the parent essential fatty acids linoleic
and a-linolenic. Various eicosanoid hormones are produced from
the 20-carbon FAs containing at kast three double bonds.
Growth experiments
MCF-7 cells (at passages 182-200) and MCF-1OA cells (at
passages 50-60) in LSM were harvested from stock cultures
in exponential growth, and passed twice through a 22 G
needle to obtain single cells. Approximately 7 x 106 MCF-7
cells per well (4 x 104 MCF-IOA cells per well) were cultured
in six-well plates (Corning) for 48 h (24 h for MCF-lOA cells)
in LSM/L-. The FAs were then introduced either bound to
BSA or in phosphatidylcholine (PC) liposomes, and incuba-
tion continued for 7 days (4 days for MCF-IOA cells). These
seeding densities and incubation times resulted in similar final
cell densities of control cells and similar variation in medium
pH (final pH 7.0-7.1 without feeding) in all experiments with
both cell lines. In all cases the cells were exposed to 30JiM
total FA or 30gM total PC. BSA-bound oleic acid (18:1,,9,
OA) (30 IM) or liposomes containing palmitic acid (16:0) at
the sn-l and OA at the sn-2 position of PC (30giM) were used
as control and as a supplement in all cases with test FA or
PC below 30gM. OA was used as control because it is a
non-essential monounsaturated FA abundant in cell mem-
branes, and at 30gM it did not affect the growth of either
MCF-7 or MCF-IOA cells as compared with growth in LSM.
Cell numbers were determined by nuclei counts as described
by Lin et al. (1991), except that cells removed from each well
with 0.5 ml of trypsin-EDTA were combined with 0.5 ml of
LSM/L- with 5% (v/v) FBS and 1 ml of 2 x hypotonic
solution (40 g 1' Triton X-100, 0.2 M citric acid). The effect
of the highest levels of exogenous lipids on cell viability was
assessed by trypan blue exclusion using cells from plates set
up in parallel with the growth experiments.
endotoxin) from The Binding Site (San Diego, CA, USA); all
phospholipids except those used as thin-layer chromato-
graphy (TLC) standards from Avanti Polar Lipids (Ala-
baster, AL, USA); fetal bovine serm (FBS, lot no. 91103)
from Bioproducts For Science (Indianapolis, IN, USA); L-
glutamine and trypsin-EDTA from Biologos (Naperville, IL,
USA); penicillin-streptomycin from Gibco; solvents from
American Burdick & Jackson (Muskegon, MI, USA); glacial
acetic acid from Fischer Scientific; 70% perchloric acid from
Mallinkrodt and BF3/methanol (14%, w/v) from Alltech. All
other chemicals, media, and supplements were purchased
from Sigma.
Cell culture
MCF-7 and MCF-IOA cells were purchased from the
American Type Culture Collection (Rockville, MD, USA) at
passages 148 and 40 respectively. To minimise interference
from serum FAs and to obtain a better defined system, all
experiments employed cells adapted for growth in low-serum
medium (LSM): A 1:1 (v/v) mixture of Dulbecco's modified
Eagle medium (DMEM) (Sigma D-5648) and Ham's F-12
(Sigma N-6760) supplemented with 15 mM HEPES, 25mM
sodium bicarbonate, L-glutamine (to 6mM), 30nM sodium
selenite, 25 mg l' human transferrin, 10 mg 1-' bovine
insulin, 10 nM 17P-oestradiol, 50jig 1' epidermal growth fac-
tor (human, recombinant), 2 mg 1-' hydrocortisone, 20 jg 1'
3,3',5-triiodo-L-thyronine, 50 jg 1 ' cholera toxin, 0.2 mM
ethanolamine, 1.5 g I' fatty acid-free BSA (final concentra-
tion in all cultures), 0.5mll1' bovine serum lipids (Sigma
L4646) and 0.5% (v/v) FBS, pH 7.4. Although LSM con-
tains components necessary for MCF-7 cell growth in the
absence of serum (Barnes & Sato, 1979; Karey & Sirbasku,
1988), it does not support MCF-7 cell growth at FBS levels
below 0.5%. MCF-7 cells grow more slowly in LSM than do
MCF-IOA cells (doubling time -48 h vs 24 h). Cells were
routinely cultured in LSM without antibiotics, and were
passaged weekly at 80-100% confluency with trypsin-
EDTA (inactivated using soybean trypsin inhibitor). In all
FA experiments LSM was used without bovine serum lipids
(LSM/L-), and was supplemented with antibiotics. All cul-
ture surfaces were coated prior to use with I jigcm 2 bovine
fibronectin (15 jg ml-' in phosphate-buffered saline, pH 7.4).
Fatty acidbining to albwnin and liposomepreparation
Cholesterol (in chloroform) and FA (5 mg) and vitamin E (in
ethanol) were sequentially added to a test tube with solvent
evaporation. BSA solution (400 g I-) was added, and the
mixture was sonicated under nitrogen using a bath sonicator,
adjusted to pH 7.4, diluted to 2.5 ml, filtered and stored at
4 C under argon. Addition of 30giM total FA to the cultures
provided 1 g 1' BSA, 12JiM cholesterol and 100 jiM vitamin
E.
Vesicles consisting primarily of PC, with the FA of interest
either at the sn-2 position with 16:0 at the sn-I position (for
OA, AA and DHA) or at both the sn- and sn-2 positions
(for LA and LNA), were prepared by probe-tip sonication
following the guidelines of Woodle and Papahadjopoulos
(1989) and Iscove (1984). The liposomes contained 1-
palmitoyl-2-oleoyl-phosphatidylserine (PS), cholesterol and
vitamin E at 1:5, 1:1 and 1:3 molar ratios to PC respectively.
Filtered (0.22jm) liposome suspensions were stored at 40C
under argon and used within 2 weeks of preparation.
Quantification by phosphorus assay and gas chromato-
graphic (GC) analysis confirmed that no appreciable loss of
material occurred during liposome or FA-BSA prepara-
tion.
Cell culture and extractionfor lipid analysis
Cultures were initiated as for the growth experiments de-
scribed above, except that 75 cm2 T flasks were used with
1.5-2.0 x 106 MCF-7 cells per flask or 1.0 x 106 MCF-1OA
cells per flask. Only the highest level (30jm FA or 30 Im
PC) of each FA was studied. Total lipid extracts were
prepared at days 3 and 6 (days 3 and 4 for MCF-1OA cells)
after FA addition using the method of Bligh and Dyer
(1959), and contained 5 ig of heptadecanoic acid (17:0,
HDA) as internal standard. Day 3 was chosen for total lipid
analysis because cultured cells are known to take up
exogenous FAs quite rapidly, and FA uptake and meta-
bolism undoubtedly precede any FA-induced growth effects.
Analysis of various glycerolipid fractions was routinely per-
formed at day 6 (day 4 for MCF-IOA cells). No discrepancies
between FA profiles at days 3 and 6 (or 4) were noted.FATTY ACID EFFECTS ON MCF-7 AND MCF-IOA CELLS 221
Thin-layer chromatography (TLC)
Prior to TLC, extracts were dried under nitrogen and redis-
solved in chloroform containing 0.1 g 1' butylated hydroxy-
toluene. Aliquots were loaded onto silica gel TLC plates,
using chloroform-methanol-acetic acid-0.15 M sodium
chloride (50:25:8:2.5, v/v) to separate and quantify the phos-
pholipid classes. The remaining material was fractionated in
a two-step TLC system [first step as above; second step in
hexane-diethyl ether-acetic acid (70:30:1, v/v)], which also
separates the neutral lipid classes. The spots were identified
by parallel analysis of phospholipid and neutral lipid stan-
dards, and analysed for FA content by GC.
Thiobarbituric acid-reactive substances andphosphorus assays
The extent of exogenous lipid peroxidation was characterised
by the level of thiobarbituric acid-reactive substances
(TBARSs), primarily malondialdehyde (MDA), measured in
spent culture medium using the method of Buege and Aust
(1978). The modified Bartlett procedure for total phosphorus
(Martinetti, 1962) was used for quantification of liposome
preparations and phospholipid classes separated by TLC.
Gas chromatography (GC)
Extracts were dried under nitrogen and redissolved in 1 ml of
GC-grade petroleum ether. FA methyl esters were prepared
using BF3/methanol (14%, w/v), and analysed by capillary
GC as previously described (Subbaiah et al., 1993). Phos-
pholipid and neutral lipid classes scraped from TLC plates
were treated directly with BF3/methanol and supplemented
with 1 #Lg of HDA.
Statistical analyses
Statistical significance of the growth results was assessed by
paired Student's t-test on the raw data from all experiments
(three experiments each in triplicate for each albumin-bound
FA; two experiments each in triplicate for each FA presented
in PC liposomes).
Results
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Fgwe 2 Effect ofa, then-3 FAs LNA (O), EPA (A) and DHA
(0) and b, the n-6 FAs LA (U) and AA (A) on the growth of
MCF-7 breast cancer cells in medium containing 0.5% FBS and
1.5gl-' BSA to which the FAs were boundL The cells were
exposed to 30gem total FA and were counted after 7 days. OA
was used as control (30 luM) and as a supplement in all cases with
test FA concentrations below 30pm. Points, mean values relative
to control for three separate experiments, each set up in triplicate
wells; bars, s.e.m. Points that are significantly different from
control with P<0.05: LNA 18pm, EPA 6pm, LA 30pM; with
P<0.01: LNA 24-30jIM, EPA 12-30jit, DHA 12-30jM, AA
18-30Lm..
Effects ofn-3 and n-6fatty acids on cellgrowth
MCF-7 cells We examined the influence of three n-3 (LNA,
EPA and DHA) and two n-6 (LA and AA) albumin-bound
FAs on the growth of MCF-7 cells (Figure 2). All n-3 FAs
tested inhibited cell growth in a dose-dependent manner
(6-30gM), with EPA and DHA being most effective. For the
n-6 FAs, LA had no effect over the same concentration
range, while AA was as inhibitory as LNA. Inhibition by
even the highest levels of FAs tested was not due to a
cytotoxic effect sine the cell number increased to at least
twice the seeding density, no appreciable cell detachment was
observed during the culture period and the viability of
attached cells at the end of each experiment never dropped
below 99%. Greater inhibition by the more highly un-
saturated FAs cannot be attributed to end products of
polyunsaturated FA (PUFA) oxidation in the medium. In
these and similar experiments (for measurement of FA incor-
poration and processing), the concentration of TBARSs in
the culture medium never exceeded 0.5 jAM at days 3, 6 and 7
of culture (results not shown).
MCF-IOA cells MCF-IOA cells were not inhibited by any of
the albumin-bound n-3 or n-6 FAs at levels below 24gM, and
were even stimulated by as much as 50% at the lower
cencentrations (Figure 3). At 30jM FA, however, the cells
were dramatically inhibited by AA and EPA, and moderately
inhibited by the remaining FAs. It is interesting to note that
MCF-1OA cells were more extensively inhibited by 30gM AA
and EPA than were MCF-7 cells. As was the case with
MCF-7 cells, growth inhibition was not due to a cytotoxic
effect, and the concentration of extracellular TBARSs never
exceeded 0.5 FiM. The differences between MCF-7 and MCF-
lOA cell growth responses to the exogenous EFAs are not
due to the different growth rates of the two cell lines because
faster growing MCF-7 cells cultured in medium containing
5% FBS were also inhibited by AA and DHA, but not by
LA. Low-serum-containing medium was used to minimise
interference from serum FAs and to enable evaluation of FA
incorporation and processing without the need for radio-
labelled compounds.
n-3 and n-6fatty acid incorporation into andprocessing by
MCF-7 cells
MCF-7 cells cultured in medium containing 5% FBS without
any other FA additions were found to contain primarily
monounsaturated FAs (54% oftotal intracellular FA, mainly
oleic and palmitoleic acids) and saturated FAs (37%). Essen-
tial FAs (mainly LA and AA) obtained from serum consti-
tuted 9% of total FA.
In order to define the EFA processing patterns of MCF-7
cells and to explain the different growth effects of LA and
AA, we measured the extent of EFA incorporation into and
processing by these cells in the same low-serum-containing
medium used in the growth experiments described above
(LSM/L-). Table I shows that the exogenous FAs were
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Fugwe 3 Effect of a, the n-3 FAs LNA (D), EPA (A) and DHA
(0) and b, the n-6 FAs LA (U) and AA (A) on the growth of
MCF-IOA non-cancerous human mammary epithelial ceils in
medium containing 0.5% FBS and 1.5 g 1' BSA to which the
FAs were bound. The cells were exposed to 30FM total FA and
were counted after 4 days. OA was used as control (30 FM) and
as a suppklment in all cases with test FA concentrations below
30iLm. Points, mean values relative to control for three separate
experiments each set up in triplicate wells; bars, s.e.m. Points that
are significantly different from control with P<0.05: LNA 6 and
24pgM, EPA 6-18 gm, DHA 6-12 um, LA 6pm, AA 12pM; with
P<O0.01: LNA 12-18 and 30Mm, EPA 30#M, DHA 30im, LA
12 and 30im, AA 30 tM.
incorporated and converted to other FAs of the same family.
Together with their processed products, the exogenous EFAs
made up as much as 40% of total intracellular FA at the
time of extraction. MCF-7 cells showed two carbon chain
elongations of the exogenous EFAs: At the time ofextraction
20% of incorporated LA and LNA was present as 20:2,,6
and 20:3,.3, respectively, and 50% of AA and 60% of EPA
was present as 22:4.4 and 22:5,3 respectively. The ability of
these cells to elongate exogenous FAs extensively appears to
be confined to those FAs containing 18 and 20 carbons, since
no evidence of 24-carbon EFA formation was obtained. Des-
pite the extensive two-carbon elongations, no appreciable
desaturations occurred except possibly at C-8 (A8; conversion
of 20:3,3 to 20:4,3). AA was not formed from LA nor EPA
and DHA from LNA. This observation is consistent with the
different growth effect of LA compared with AA and of
LNA compared with EPA and DHA (Figure 2). Some retro-
conversion, or chain shortening, also occurred. At the time of
extraction, one-quarter of DHA was present as EPA. Some
AA (about 5%) was present as 20:3,6 and possibly 18:3,.
The DHA to EPA retroconversion is known to occur in a
variety of animal tissues, while retroconversion of AA is not
as well documented (Rosenthal et al., 1991).
Table II describes the lipid class distribution of exogenous
FAs in MCF-7 cells. While LA, AA and LNA were equally
distributed between the major phosphoglycerides [PC and
phosphatidylethanolamine (PE)], DHA and EPA showed
greater incorporation into PE. However, since total PE is
only half as abundant as total PC, all EFAs actually enriched
PE to a greater extent than PC. Preferential incorporation of
DHA and EPA into PE has been observed in a variety of
tissues (Careaga-Houk & Sprecher, 1989; Yeo & Holub,
1990). Between the minor phosphoglycerides examined [phos-
phatidylinositol and phosphatidylserine (PI + PS) and phos-
phatidic acid (PA)], LA and LNA were incorporated to a
greater extent into PA, with AA, EPA and DHA incor-
porated to a greater exent into PI+ PS. Despite the
differences in the relative incorporation of exogenous EFAs
into phosphoglyceride classes, there was very little effect of
the different exogenous EFAs on the total amount of each
phosphoglyceride class. Not only the original EFAs, but also
the various EFAs derived from them, were extensively incor-
porated into all phosphoglycerides (data not shown). Because
all phospholipids were enriched, and because only a small
fraction of the exogenous EFA existed in free form (<13%)
or was incorporated into triacylglyceride (TAG) (<1%), it is
likely that the observed growth effects were mediated by
phospholipids.
n-3 and n-6fatty acid incorporation into andprocessing by
MCF-IOA cells
Table III describes the fate of exogenous n-3 and n-6 FAs in
MCF-IOA cells. To the best of our knowledge, this is the first
report of EFA processing in cultured non-cancerous human
mammary cells. The added FAs were extensively incor-
porated, although to a lesser extent than by MCF-7 cells.
Unlike MCF-7 cells, MCF-1OA cells showed desaturation
and elongation of the exogenous FAs via all the known
pathways. For example, 28% of LA present at time of
extraction was converted to AA, 21% of LNA to EPA and
14% of EPA to DHA. Whether the last conversion occurs
via the action of a A4 desaturase (classical pathway) or via
24-carbon PUFA intermediates, as recently proposed by Voss
et al. (1991), was not addressed in our study. MCF-IOA cells
retroconverted DHA to EPA, AA to 20:3." and 18:3" and
EPA to 20:4,,3. The last retroconversion was not observed in
MCF-7 cells. The EFA-processing patterns ofMCF-1OA cells
are consistent with the observed growth effects (Figure 3). In
contrast to MCF-7 cells, the effects of LA and AA on
MCF-IOA cell growth were qualitatively the same, consistent
with these cells' ability to produce substantial amounts of
AA from LA.
Table IV shows that, as for MCF-7 cells, all the phospho-
glycerides of MCF-IOA cells were enriched in the exogenous
FAs. In MCF-IOA cells, not only EPA and DHA but also
AA were found predominantly in PE as opposed to PC. LA,
and to a lesser extent LNA, was found mostly in PC.
Between the minor phosphoglycerides, LA and LNA ended
up in PA, and AA and DHA were incorporated into
PI + PS, as was the case in MCF-7 cells (Table II). In
MCF-IOA cells, EPA clearly favoured PI + PS as well.
Finally, MCF-1OA cells contained more TAG and less free
FA than MCF-7 cells. This observation may be related to the
fact that lipid accumulation in the form of lipid droplets is
characteristic of a more differentiated mammary epithelial
cell (Guilbaud et al., 1990).
Effects ofn-3 and n-6fatty acids presented as phospholipid
liposomes to MCF-7 cells
In one study, Imagawa et al. (1989) observed that phos-
pholipids containing PUFAs were mitogenic for normal
mouse mammary epithelial cells in serum-free primary cul-
ture. In order to investigate whether the method of EFA
supplementation plays a role in the observed growth effects
on MCF-7 cells, we compared the effects of EFAs introduced
either as acyl groups of PC in phospholipid vesicles or as free
FAs bound to albumin. Figure 4 shows that similar trends
were observed for the growth effects of the exogenous EFAs
with the two methods of supplementation, namely a dose-
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dependent (6-30 LM FA or PC) growth inhibition by AA,
LNA and DHA and no effect of LA. Similar inhibition by
AA, LNA and DHA presented in phospholpid liposomes
and as albumin-bound free FAs might suggest that the two
methods are equivalent. However, the extent ofincorporation
into MCF-7 cells of EFAs presented as PC was only
25-50% as much as that obtained with EFAs presented
bound to albumin, depending on the EFA. Table V shows
that the cellular enrichment in n-3 FAs due to DHA pro-
vided at the sn-2 position of PC in liposomes was about
Tab I Fatty acid profile of MCF-7 breast cancer cells at day 3 of exposure to various
unsaturated fatty acidsa
Percentge of total fatty acid'
n-6 Fatty acid n-3 Fatty acids
Fatty acid OA LA AA LNA EPA DHA
Saturated' 20.1 24.4 29.4 25.1 30.8 35.0
Monounsaturatedd 71.3 27.4 27.3 25.5 29.2 29.7
n-6 FAs
18:2 (LA) 0.9 31.7 1.1 1.2 0.9 1.5
18:3 NDI ND 0.8 ND ND ND
20:2 0.1 8.2 0.1 0.3 0.1 ND
20:3 0.2 ND 1.6 ND 0.1 ND
20:4 (AA) 0.9 0.5 17.2 0.7 1.0 0.9
22:2 ND 1.1 ND ND ND ND
22:3 ND 0.6 ND ND ND ND
22:4 0.2 0.4 17.2 ND ND ND
22:5 ND ND ND ND ND ND
n-3 FAs
18:3 (LNA) 0.1 0.1 0.1 28.7 0.2 ND
18:4 ND ND ND ND ND ND
20:3 ND ND ND 8.2 ND ND
20:4 ND ND ND 2.6 0.8 0.6
20:5 (EPA) ND ND ND ND 12.3 7.4
22:3 ND ND ND 1.3 ND ND
22:4 ND ND ND 2.1 ND ND
22:5 ND ND ND ND 21.3 2.1
22:6 (DHA) 0.1 0.2 0.2 0.1 0.2 20.0
Unknown at RRT=1.289 0.1 1.9 ND 0.2 ND ND
All other unknown FAsg 6.0 3.5 5.0 4.0 3.1 2.8
aDatareflcthte results of oncexpeAiment for each EFA added at 30 u.; simila results
wem obtained for a rep texperient for each EFA. bTotal fatty aad content in each
treatment case was (per 0' cells): OA, 50.0; LA, 54.3; AA, 70.8; LNA, 62.6; EPA, 68.0;
DHA, 51.8pg 'Saturated FAs inclde 14:0, 16:0 and 18:0. *Monounsaturated FAs
include 16:1,7, 18:1,., (OA), 18:1,7, 20:1,,,, 20:1,7 and 22:1,., eND, none detected
(<0.1%). tThis unitified peak occurs between 20:2., and 20:3., and incases only
with LA treatment. RRT, relative retention time (with rspect to 18:2.,). 'his row
represents the sum ofthe contents ofal u ed peaks which do not change a ably
under any treatment.
Table I Distribution of exogenous fatty acid in glycerolipids and in the
intracellular free FA (FFA) fraction of MCF-7 cells at day 6 of exposure to
various unsaturated fatty acids'
Percentage of exogemuS FAb VI each hpid claTss
Fatty acid PC" PE PI+PS PA TAG FFA
18:2,. 33.4 38.5 8.7 14.4 1.0 4.0
(LA) (49.3)e (29.7) (12.9) (4.0) [3.2r [13.6]
20:4,6 38.8 39.4 17.5 4.3 ND' ND
(AA) (50.2) (27.1) (13.3) (4.0) [3.6] [5.7]
18:3,3 32.7 30.8 8.2 13.6 1.0 13.7
(LNA) (51.9) (22.7) (13.4) (3.9) [3.0] [39.4]
20:5,3 31.2 57.3 9.5 2.0 ND ND
(EPA) (49.4) (28.0) (13.2) (4.2) [1.6] [8.3]
22:6,3 16.9 41.3 24.7 8.6 ND 8.5
(DHA) (51.6) (26.0) (13.1) (3.9) [3.4] [10.3]
'Data reflt the results of one expeinment for each EFA added at 30Jm;
similar trends were observed in a repicatc expiMmet for each EFA. "Total
exogenous FA content in each treatment case was (per 10' cells): LA, 16.4; AA,
9.8; LNA, 10.9; EPA, 7.2; DHA, 8.3 ag (does not include exogenous FAs
converted to other FAs of the same family). 'Exchlfing sphingomyelin and
lyso-PC, which were not analysed dA'ny choline plasmalog are included in
this class since they arc not separable by our method. Similarly, ethanolamine
plasinaogens are incuded in the PE class. eValues in parentheses give the relative
amount (mol%) of each phospholpid in MCF-7 cells as determined by
phosphorus assay. Typically, sphingomyehn and lyso-PC constituted 5-6% and
<1% ofphospholpids rspectively (data not shown). 'Values in square brackets
give the relative amount of neutral lpids based on wt% of total
(endogenous + eogenous) FA measured in each fraction by GC. 'ND, none
detected.224 S.I. GRAMMATIKOS et al.
one-quarter that obtained after supplementation with
albumin-bound DHA. This is consistent with the enrichment
in n-3 FAs due to LNA from 30gM dilinolenoyl PC (total
LNA content of 60pM), which was half that achieved with
30#LM albumin-bound LNA. In contrast, LA from dilinoleoyl
PC and AA from the sn-2 position of PC led, respectively, to
the same and one-half the enrichment in n-6 FAs compared
with albumin-bound free LA and AA (data not shown).
More extensive incorporation of LA compared with LNA
and of AA compared with DHA suggests that different
liposomes are taken up to different extents.
Inhibition of MCF-7 cell growth by n-3 FAs, but not by LA
(n-6), is consistent with the different effect of fish oil com-
pared with corn oil in rat models of mammary carcinogenesis
Table m Fatty acid profile of MCF-1OA non-cancerous mammary cells at day 3 of
exposure to various unsaturated fatty acidsx
Percentage of total fatty acid'
n-6 Fatty acids n-3 Fatty acids
Fatty acid OA LA AA LNA EPA DHA
Saturatedc 28.1 34.8 37.1 36.1 34.5 35.0
Monounsaturatedd 50.7 26.0 23.8 15.4 30.1 27.1
n-6 FAs
18:2 (LA) 0.2 5.3 0.3 0.5 0.2 0.4
18:3 NIY 0.5 0.5 ND ND ND
20:2 ND 0.8 0.3 0.3 0.3 0.2
20:3 0.3 8.5 4.0 0.5 0.3 0.2
20:4 (AA) 0.7 7.4 12.4 0.4 0.5 0.5
22:2 ND 0.3 0.2 0.1 0.1 0.1
22:3 ND 0.7 0.3 ND ND ND
22:4 0.2 3.1 6.5 ND ND ND
22:5 ND 0.5 3.4 ND ND ND
n-3 FAs
18:3 (LNA) ND 0.1 ND 7.6 0.1 0.4
18:4 ND ND ND 1.2 0.1 0.3
20:3 ND ND ND 2.9 ND ND
20:4 ND ND ND 15.1 1.4 1.3
20:5 (EPA) ND ND ND 6.6 11.8 8.0
22:3 ND ND ND 0.2 ND ND
22:4 ND ND ND 1.2 ND ND
22:5 ND ND ND 3.4 6.6 2.0
22:6 (DHA) 0.1 0.1 0.2 0.3 3.2 12.4
All unknown FAsf 19.7 11.9 11.0 8.2 10.8 12.1
"Data reflect the results of one experiment for each EFA added at 30pm; similar results
were obtained for a repicate e rent for each EFA. "Total fatty acid content in each
treatment case was (per 10' cells): OA, 39.0;, LA, 41.9; AA, 61.9, LNA, 41.0; EPA, 58.5;
DHA, 53.6pg. cSaturated FAs inclhde 14:0, 16:0 and 18:0. 'Monounsaturated FAs
include 16:1,7, 18:1, (OA), 18:1,7, 20:1,., 20:1.7 and 22:1 'ND, none detected
(<0.1%). fThe unknowns include increased klvels of unassigned peaks observed between
14:0 and 18:0, possibly arising from plasmakogens and (in the case of OA) unassigned
peaks in the vicinity of 20:2, and 22:2.4 possibly arising from n-9 dienoic FAs.
Table IV Distribution of exogenous fatty acid in glycerolipids and in the
intracellular free FA (FFA) fraction of MCF-IOA cells at day 4 of exposure to
various unsaturated fatty acidse
Percentage of exogenous FAb in each ijpid class
Fatty acid PCS PE PI+ PS PA TAG FFA
18:2., 41.5 17.6 8.3 26.5 5.8 0.3
(LA) (43.0r (29.8) (15.0) (5.8) [6.9f [1.4]
20:4.6 15.6 59.0 17.0 5.9 2.4 0.1
(AA) (54.5) (18.5) (15.1) (4.8) [8.5] [1.3]
18:33.3 37.7 24.7 4.1 14.7 17.6 1.2
(LNA) (49.4) (24.3) (15.1) (4.0) [10.3] [1.7]
20:533 15.8 57.8 21.0 1.7 3.3 0.4
(EPA) (47.9) (25.3) (14.4) (4.8) [8.7] [2.7]
22:6,3 14.3 43.4 22.6 11.3 7.2 1.2
(DHA) (49.1) (25.3) (13.9) (5.2) [7.6] [2.0]
'Data rflect the results ofone experiment for each EFA added at 30gsm; simclar
trends were observed in a replicate experiment for each EFA. 'Total exogenous
FA content in each treatment case was (per 10' ceUls): LA, 1.9; AA, 5.8; LNA, 2.7;
EPA, 3.4; DHA, 3.1 pg (does not include exogenous FAs converted to other FAs
of the same family). cExduding sphingomyein and Iyso-PC, which were not
analysed dAny choline pLasmalogens are included in this class since they are not
separable by our method. Similarly, ethanolamine plasinalogens are included in the
PE class. 'Values in parentheses give the relative amount (mol%) of each
phospholipid in MCF-7 cells as determined by phosphorus assay. Typically,
sphingomyein and lyso-PC constituted 5-6% and < 1% of phospholipids
respectively (data not shown). 'Values in brackets give the relative amount of
neutral lipids based on wt% of total (endogenous + exogenous) FA measured in
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(Caroll & Hopkins. 19-9: Hubbard & Erickson. 198-: Katz
& Bovlan. 198-: Pritchard et al.. 1989; Cave. 1991 . AWhile
inhibition by AA appears to be paradoxical. it should be
noted that corn oil contains very little AA. The differing
effect of LA compared w-ith AA and the less extensive inhibi-
tion by LNA compared wxith EPA and DHA suggest that
differences also exist among FAs of the same family.
a
2-,
WN-icha et al. ( 19-9) e-aluated the effect of FAs on the
growxth of primarn. normal rat mammar- epithelial cells and
rat mammary tumour cells induced b- I.1'-dimethNl-
benz[xjanthracene. Both cell types x-ere stimulated bv LA in
the concentration range 0.1 - 10 jig ml- (0.36-36 pjm. LNNA
also stimulated the grow-th of both cell tvpes in the low-er end
of the concentrations studied (0.36- 3.6 pjm. although the
c
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Figure 4 Companson o: the effect-s ot a. AN. b. LA. c. DHA and d. LNA presented as albumin-bound free FA _ or in
phospholipid liposomes on the arowth of NICF-- breast cancer cells In both cases. the medium contained 0 50o FBS and
1 5 a I BSA The cells "ere exposed to 30 )NI total FA or 30 !14 total PC and were counted after - days Albumin-bound OA or
liposomes containing 16-U at the Sn-l and OA at the sn-2 position of PC were used a-, control and as a supplement in all casesw ith
test FA or PC below 0 II Points. mean values relative to control for three separate experiments with albumin-bound FAs and
tw-o separate expenments- -ith lipo-omens. each set up in triplicate i-ells bars. s e m Significantly different cell number compared
with control "P<il.05 P<0 01
Table V Companrson of the effects of two methods of supplementation on n-3 fattx acid
incorporation into and processing b! MICF-- breast cancer cell- at da! of expo-sure to
various unsaturated fattx acidsa
Saturated-
Xfonounsaturated
S. iLNA
20 EP.) 20 5.
EP
6D -DHA.
Total n-6 F.A-
All unknown FAS-
Percenraee atr total tart-i aciLd-
l4lbunin-boundi in lipooorSntOt
0.4 L'O.4 DHIA 04 LN4-; DH.4
21). 1
1.
ND
N-D
ND
ND
ND
ND
N-D
Q. 1
6-1
1
ND
_2.6
N-D
13'
_1
N-D
I
4 _'
I ;.O
29
ND
N-D
ND
06
--4
-ND
ND
1.I
2.4
"I},Q
b
61.
'
ND
N-D
ND
ND
ND
ND
N-D
ND
ND
1_6
6.6
34
- .0
14.1
ND
_4._'
ND
0.6
21.
ND
ND
1.4
4.0
29 !
5r4. 9
0.1
ND
N-D
N-D
N-D
ND
0.2
2.
-Data reflect the resultS- of one expenment for each EFA added at 30 ANI EFA or PC.
similar results w-ere obtained in replicate expe ments for each EFA 'Total fatt-. acid
content in each treatment case Aas li for albumin-bound (per 10' cells) OA. 39.0. LNA.
41 9: DHA. 1 jg. and (ii) for liposomes (per 10^ cells) OA. 56 5. LN-A. 41 9. DHA.
54 5 Pg -Unles- otherwise indicated the test FA-. were supplied onlx at the Sn-2 position of
PC iwith 16 0 at the sn-I positioni Lipo.Some-. also -supplied 6Aei I-palmitov-l-2-oleovl-PS
Dilinolenovl PC ND. none detected (<( 10o. This row represents the sum of the
content- of all unassigned peaks w-hich do not change appreciably under anx treatment226 S.1. GRAMMATIKOS et at.
stimulation was substantialy more pronounced in normal
cells. In contrast, normal cells wereinhibited by AA levels
>3gM. While direct comparison of our results with those of
Wicha et al. (1979) is not possible, in both studies mammary
tumour cells were not inhibited by LA at concentrations for
which other FAs were inhibitory.
Our results are in qualitative agreement with the effects of
EPA, DHA and LA reported by Rose and Connolly (1989,
1990) for the human breast cancer cell lines MDA-MB-231
and MCF-7. DHA, and to alesser extent EPA,inhibited
MDA-MB-231 cell growth in a dose-dependent manner
(1.5-7.5 pM). However, LA was found to stimulate the
growth of MDA-MB-231 and, to a lesser extent, MCF-7
cells. Stimulation of MDA-MB-231 cells was optimal at
0.75 pg ml' (2.7 pM), and was abolished at higher concen-
trations (6-30gM). Although Rose and Connolly (1990)
noted a dose-dependent inhibition of MDA-MB-231 cell
growth byOA concentrations above 3 gM, no such inhibitory
effect was noted in our studies with MCF-7 (or MCF-IOA)
cells, even at 30 pM. The lack of an effect ofOA on MCF-7
cell growth has also been reported by others, even for con-
centrations exceeding 100 pm (Borras & Lckec, 1992). The
different effect ofOAin the two beast cancer cell lnes may
be due to differences in sensitivity to exogenous FA exposure.
In our hands MDA-MB-231 cells are extremely sensitive to
any FA addition above 10pIM, with AA, EPA and DHA all
severely cytotoxic (unpublished observations).
The growth-inhibitory and sometimes cytotoxic effects of
PUFAs on cancer cells are often explained in terms of the
intracellular fatty acids' susceptibility to oxidation (Begin et
al., 1986; Horrobin, 1989, 1990). It has recently been
reported that breast cancer cells are more susceptible to
PUFA peroxidation than are normal cells (Takeda et al.,
1992). We minimised oxidation of easily oxidisable PUFAs
(with three or more double bonds) during preparation,
storage and incubation in the extracellular miieu by supply-
ing vitamin E (100pgM; 3:1 molar ratio to FA) with the
FA-BSA complexes. We measured the concentration of
TBARSs in the culture medium as a crude indicator of the
overall level of lipid peroxidation. In our system greater
inhibition by the more highly unsaturated FAs cannot be
attributed to end products of extracellular PUFA oxidation.
The concentration of TBARSs in the culture medium never
exceeded 0.5FM, while growth-inhibitory effects of MDA
have only been reported for levels above 100pM (Bird &
Draper, 1980). Although we did not measure the extent of
intracellular PUFA peroxidation, it is reasonable to expect
that vitamin E (a potent inhibitor of lipid peroxidation;
Cheeseman et al., 1984) inhibited this reaction as well. In this
regard it should be noted that, in the nude mouse model,
antioxidants prevented the inhibitory effects of n-3 FAs on
MCF-7 tumour cell growth (Gonzalez et al., 1991).
Tberefore, it is likely that the inhibition of MCF-7 cell
growth we observed with LNA, AA, EPA and DHA is due
to factors other than lipid peroxidation.
Many animal cells are deficient in one desaturating
enzyme, usually A6 or A4 (Dunbar & Bailey, 1975; Maeda et
al., 1978; Robert et al., 1978). Extensive two-carbon elonga-
tions in the absence of appreciable A4, A', A6 or A7 destura-
tions, as observed here for MCF-7 cells, have not been
previously reported. Reduced rates or the complete absence
of A6 desaturation has been described in rat tumours ex vivo
(Bartoli et al., 1980, Cheeseman et al., 1984). Furthermore,
many but not all transformed or malignant cell lines in vitro
have a reduced capacity for A6 desaturation (Dunbar &
Bailey, 1975; Maeda et al., 1978; Iturralde et al., 1990; Marra
& de Alaniz, 1992; Naval et at., 1993).
Tlhe relationship between A' desaturation and cancer re-
mains unclear, but Horrobin (1989, 1990) suggests that A6
desaturation plays a key role in human cancer and in breast
cancer in particular. Lack of A' desaturation may render cells
unable to safely accommodate 6-desaturated EFAs. This may
be responsible for the cancer cells' susceptibility to AA, EPA
and DHA. In this regard it should be noted that y-linolenic
acid (18:3.6), abo a 6-desaturated EFA, has been reported to
exert cytotoxic effects on cancer cells from various tissues
(B&gin et al., 1986). In contrast to MCF-7 cells, MCF-1OA
cells are much more resistant to AA, EPA and DHA at
concentrations below 30pM, consstent with these cells'
ability to produce substantial amounts of these FAs from LA
and LNA. Although thedisnct differences in EFA process-
ing between the MCF-1OA and MCF-7 cell lines may be
related to tumour progression, further studies with a variety
of normal and cancerous cell lines and primary cells are
necessary to confirm this hypothesis. The possibility must be
considered that MCF-1OA cells desaturate exogenous FAs
more extensively than MCF-7 cells because of their faster
growth rate. At 30pM FA, however, MCF-1OA cells were at
kast as inhibited as MCF-7 cells. We would expect that the
main effect of doubling time on EFA metabolism would be
observed between quiescent and actively dividing cells. The
finding of Bandyopadhyay et al. (1987) that both growing
and non-growing mouse mammary epithelial cells metabolise
LA to AA and protaglandin E2 suggests that the differences
in EFA processing between MCF-7 and MCF-IOA cells are
not the result of differences in growth rate. It must be
empasd that the differences in EFA processing may not
account for the observed inhibition of MCF-7, but not
MCF-IOA, cell growth by the n-3 FAs and AA at concentra-
tions below 30pM.
The fact that AA, LNA and DHA supplied in PC
liposomes were as inhibitory to MCF-7 cell growth as the
albumin-bound free FAs even though only 25-50% as much
EFA was incorporated suggests different mechnis of
growth inhibition for the two forms of EFA supplementa-
tion. Introduction of EFAs in PCliposomes may upset their
distribution across thephospholipid classes. Indeed, the dist-
ribution of exogenous EFAs in phosphoglycerides obtained
when the EFAs were presented in PC lposomes was different
from that obtained withalbumin-bound free FAs. For exam-
ple, the ratio of PC-bound to PE-bound DHA increased
from 0.4 to 1.0 when this FA was supplied as PC rather than
bound toalbumin. For AA, the same ratio increased from
1.0 to 1.6. Just how sensitive the cell is to such changes
remains to be determined. However, despite the increased
ratio of PC-bound to PE-bound exogenous EFA, addition of
exogenous PC did not alter the relative amounts of total PC
and PE in MCF-7 cells (50.5% ± 1.2% PC and
26.7% ± 2.6% PE for the albumin method compared with
50.3% ±1.2% PC and 21.3% ± 2.1% PE for the liposome
method). In addition, examination of the FA profiles of
individual phosphoglyceride classes of liposome-supple-
mented MCF-7cells reveals that all are enriched in the test
EFAs (data not shown). These results suggest that the cell
attempts to regulate the total phospholipid distribution and
the composition of each class.
Endothdial cells produce enzymes that oxidiselipoproteins
on the cell surface (Steinberg etal., 1989) and may be able to
act on the PC of liposomes as well. Therefore, the possibility
ofextracellular effects ofliposomes, such as enzyme-induced
peroxidations of the unsaturated FAs at the cell surface,
cannot be excluded. In this regard it should be noted that the
final vitamin E content was 10,M in liposome experiments
(1:3 molar ratio to PC), whereas in experiments with
albumin-bound free FAs it was 100pgM (3:1 molar ratio to
FA). However, no increase in TBARS concentration was
measured even under the most inhibitory liposome condi-
tions. Furthermore, the observed inhibitions were not due to
a cytotoxic effect, since cell viability never dropped below
99% and 2- to 3-fold expansion in cell number was obtained
even with the most inhibitory liposomes.
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